|
Market Closed -
Nasdaq
01:30:00 23/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.5162 USD | -8.18% |
|
+3.26% | -91.57% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
5ad039205d8de69.rmEMeTSTHttc8OwSoB2tgEQAF0KEHP_hGmdljnCAVGs.yBNnIE7-f44tupk_7yvmsiJPRC62Zs3UQz8d6SnEMTvMC11NQMEsoxa9qQ~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| +2,163.33% | ||||||
| +35.78% | ||||||
| +28.93% | ||||||
| +10.89% | ||||||
| +8.75% | ||||||
| +14.18% | ||||||
| +37.21% | ||||||
| +37.85% | ||||||
| +32.7% | ||||||
| +4.59% | ||||||
| Average | +237.42% | |||||
| Weighted average by Cap. | +23.89% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5162USD
Average target price
11.68USD
Spread / Average Target
+2,163.33%
High Price Target
15.05USD
Spread / Highest target
+2,815.54%
Low Price Target
8.000USD
Spread / Lowest Target
+1,449.79%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















